Co-Diagnostics, Inc.
CODX
$0.34
-$0.01-2.01%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -29.72% | 1.12% | -80.09% | 170.47% | 51.58% |
| Total Other Revenue | -- | -- | -- | -100.00% | -81.29% |
| Total Revenue | -77.32% | -93.87% | -89.25% | -95.80% | -73.91% |
| Cost of Revenue | -91.16% | -84.87% | -90.79% | -91.40% | 16.26% |
| Gross Profit | -65.35% | -94.65% | -87.70% | -118.00% | -84.39% |
| SG&A Expenses | -55.40% | -23.10% | -23.48% | 12.10% | 5.84% |
| Depreciation & Amortization | -23.86% | -13.86% | -15.18% | 14.13% | 18.53% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -34.17% | -20.47% | -19.81% | -21.61% | -4.54% |
| Operating Income | 31.47% | -4.92% | 16.64% | -0.69% | -14.54% |
| Income Before Tax | 27.09% | -1.84% | 19.03% | -1.82% | -19.50% |
| Income Tax Expenses | -5,354.95% | -40.29% | -47.37% | -100.21% | 101.05% |
| Earnings from Continuing Operations | 39.29% | -1.72% | 19.10% | 24.84% | -62.09% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 39.29% | -1.72% | 19.10% | 24.84% | -62.09% |
| EBIT | 31.47% | -4.92% | 16.64% | -0.69% | -14.54% |
| EBITDA | 31.74% | -5.79% | 16.69% | -0.33% | -14.40% |
| EPS Basic | 51.13% | 7.45% | 24.65% | 28.27% | -56.11% |
| Normalized Basic EPS | 42.97% | 1.11% | 20.26% | 0.79% | -10.74% |
| EPS Diluted | 50.00% | 7.45% | 23.08% | 28.08% | -57.09% |
| Normalized Diluted EPS | 42.97% | 1.11% | 20.26% | 0.79% | -10.74% |
| Average Basic Shares Outstanding | 24.26% | 9.90% | 7.39% | 4.78% | 3.86% |
| Average Diluted Shares Outstanding | 24.26% | 9.90% | 7.39% | 4.78% | 3.86% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |